TargetMol

AH 7079

Product Code:
 
TAR-T29738
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T29738-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
AH 7079 is a biochemical.
CAS:
33440-58-3
Formula:
C15H10N4O3
Molecular Weight:
294.27
Purity:
0.98
SMILES:
COc1ccc2oc3ccc(cc3c(=O)c2c1)-c1nnn[nH]1

References

1. Al-Ali H, Ding Y, Slepak T, Wu W, Sun Y, Martinez Y, Xu XM, Lemmon VP, Bixby JL. The mTOR Substrate S6 Kinase 1 (S6K1) Is a Negative Regulator of Axon Regeneration and a Potential Drug Target for Central Nervous System Injury. J Neurosci. 2017 Jul 26;37(30):7079-7095. doi: 10.1523/JNEUROSCI.0931-17.2017. Epub 2017 Jun 16. PubMed PMID: 28626016; PubMed Central PMCID: PMC5546395. 2. Kendrick J, Holmen J, You Z, Smits G, Chonchol M. Association of Unilateral Renal Agenesis With Adverse Outcomes in Pregnancy: A Matched Cohort Study. Am J Kidney Dis. 2017 Oct;70(4):506-511. doi: 10.1053/j.ajkd.2017.02.367. Epub 2017 Apr 7. PubMed PMID: 28396109; PubMed Central PMCID: PMC5610923. 3. Morita FH, Bernardo WM, Ide E, Rocha RS, Aquino JC, Minata MK, Yamazaki K, Marques SB, Sakai P, de Moura EG. Narrow band imaging versus lugol chromoendoscopy to diagnose squamous cell carcinoma of the esophagus: a systematic review and meta-analysis. BMC Cancer. 2017 Jan 13;17(1):54. doi: 10.1186/s12885-016-3011-9. PubMed PMID: 28086818; PubMed Central PMCID: PMC5237308. 4. Higashimori H, Schin CS, Chiang MS, Morel L, Shoneye TA, Nelson DL, Yang Y. Selective Deletion of Astroglial FMRP Dysregulates Glutamate Transporter GLT1 and Contributes to Fragile X Syndrome Phenotypes In Vivo. J Neurosci. 2016 Jul 6;36(27):7079-94. doi: 10.1523/JNEUROSCI.1069-16.2016. PubMed PMID: 27383586; PubMed Central PMCID: PMC4938857.